Impaired regulation and resultant aberration in the expression and/or activity of cadherins have been associated, or better put, implicated in several pathological condition, including nephropathies, autoimmune diseases, and malignancies [27,28,29]. The gene discussed is CDH17; the disease is autoimmune disease.